Vascular risk factors and Alzheimer's disease

Australian and New Zealand Journal of Psychiatry

Volumn 33, Issue 6, 1999, Pages 809-813

  Stewart, R ^a   Prince, M ^a   Mann, Anthony ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Alzheimer's disease; Cardiovascular disease; Diabetes; Hypertension; Stroke

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; INSULIN;

AGING; ALZHEIMER DISEASE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN RESISTANCE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; VASCULAR DISEASE;

EID: 0033372336     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.1999.00657.x     Document Type: Conference Paper

References (41)

1. Mc Khann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
2. Roman GC, Tatemichi TK, Erkinjuntti T et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:1609-1611.
3. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology 1996; 47:1113-1124.
4. Holmes C, Cairns N, Lantos P, Mann A. Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies. British Journal of Psychiatry 1999; 174:45-50.
5. Kokman E, Whistman JP, O'Fallon WM, Chu CP, Beard CM. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology 1996; 19:154-159.
6. Yoshitake T, Kiyohara Y, Kato I et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama Study. Neurology 1995; 45:1161-1168.
7. Prince M, Cullen M, Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology 1994; 44:97-104.
8. Ott A, Breteler MMB, de Bruyne MC, van Harskamp F, Grobee DE, Hofman A. A trial fibrillation and dementia in a population-based study. Stroke 1997; 28:316-321.
9. Hofman A, Ott A, Breteler MMB et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997; 349:151-154.
10. van Duijn CM. Genetic and environmental factors and the incidence of Alzheimer's disease. Neurobiology of Aging 1998; 19:S227.
11. Farmer ME, White LR, Abbott RD et al. Blood pressure and cognitive performance: the Framingham Study. American Journal of Epidemiology 1987; 126:1103-1114.
12. Launer LJ, Masaki K, Petrovitch H, Foley D, Havlik RJ. The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. Journal of the American Medical Association 1995; 274:1846-1851.
13. Kuusisto J, Koivisto K, Mykkanen L et al. Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study. British Medical Journal 1997; 315:1045-1049.
14. Guo Z, Viitanen M, Fratiglioni L, Winblad B. Low blood pressure and dementia in elderly people: the Kungsholmen project. British Medical Journal 1996; 312:805-808.
15. Katzman R, Aronson M, Fuld P et al. Development of dementing illness in an 80-year-old volunteer cohort. Annals of Neurology 1989; 25:317-324.
16. Skoog I, Lernfelt B, Landahl S et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347:1141-1145.
17. Forette F, Seux M-L, Staessen JA et al. Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352:1347-1351.
18. Prince MJ, Bird AS, Blizard RA, Mann AH. Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. British Medical Journal 1996; 312:801-805.
19. Applegate WB, Pressel S, Wittes J et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. Archives of Internal Medicine 1994; 154:2154-2160.
20. Ott A, Stolk RP, Hofman A, van Harskamp F, Grobbee DE, Breteler MMB. Association of diabetes mellitus and dementia: The Rotterdam Study. Diabetologia 1996; 39:1392-1397.
21. Ott A, Stolk RP, van Harskamp F, Breteler MMB. Diabetes mellitus and the risk of dementia in an elderly population. In: Ott A, ed. Risk of Dementia. The Rotterdam Study. Delft: Judels En Brinkman BV, 1997:49-62.
22. Reaven GM. Role of Insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
23. Prince MJ. Vascular risk factors and atherosclerosis as risk factors for cognitive decline and dementia. Journal of Psychosomatic Research 1995; 39:525-530.
24. Riggs JE. Smoking and Alzheimer's disease: protective effect or differential survival bias? Lancet 1993; 342:793-794.
25. Canadian Study of Health and Aging. Risk factors for Alzheimer's disease in Canada. Neurology 1994; 44:2073-2080.
26. Ott A, Slooter AJC, Hofman A. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998; 351:1840-1843.
27. Notkola I, Sulkava R, Pekkanen J. Serum total cholesterol, apolipoprotein E ε4 allele, and Alzheimer's disease. Neuroepidemiology 1998; 17:14-20.
28. Kalmijn S, Launer LJ, Ott A. Dietary fat intake and the risk of incident dementia in the Rotterdam Study. Annals of Neurology 1997; 42:776-782.
29. Marin DB, Breuer B, Marin ML et al. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis 1998; 140:173-180.
30. Prince M, Lovestone S, Cervilla J, Mann A. The association between ApoE and dementia is mediated neither by vascular disease nor its risk factors in an aged cohort of survivors with hypertension. Neurology (in press).
31. Tang MX, Maestre G, Tsai WY et al. Effect of age, ethnicity, and head injury on the association between APOE genotypes and Alzheimer's disease. Annals of the New York Academy of Science 1996; 802:6-15.
32. Itzhaki RF, Lin W, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 1997; 349:241-244.
33. Ukkola O, Kervinen K, Salmela PI, von Dickhoff K, Laakso M, Kesäniemi YA. Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus. Atherosclerosis 1993; 101:9-15.
34. Stewart R. Cardiovascular factors in Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry 1998; 65:143-147.
35. Sparks DL, Scheff SW, Liu H, Landers TM, Coyne CM, Hunsaker JC. Increased incidence of neurofibrillary tangles in non-demented individuals with hypertension. Journal of Neurological Science 1995; 131:162-169.
36. Hall ED, Oostveen JA, Dunn E, Carter DB. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils. Experimental Neurology 1995; 135:17-27.
37. de la Torre JC, Mussivand T. Can disturbed brain micro-circulation cause Alzheimer's disease? Neurological Research 1993; 15:146-153.
38. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabetic Medicine 1999; 16:93-112.
39. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR. Brain infarction and the clinical expression of Alzheimer disease. Journal of the American Medical Association 1997; 277:813-817.
40. Hoffman RM, Garewal HS. Antioxidants and the prevention of coronary heart disease. Archives of Internal Medicine 1995; 155:241-246.
41. Markesbery WR. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biology in Medicine 1997; 23:134-147.